Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.51
Delayed Data
As of 9:45am ET
 +0.12 / +3.54%
Today’s Change
2.88
Today|||52-Week Range
5.18
-10.46%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Brainstorm Cell Therapuetics Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 9.00. The median estimate represents a +156.41% increase from the last price of 3.51.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Brainstorm Cell Therapuetics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.32
Sales
--
Reporting Date
May 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3,300.00%
 
 
 
 
 
 
Growthannually -350.00%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.